| 18th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 18th Jul 2025 7:00 am |
RNS |
Blenrep US ODAC outcome |
| 17th Jul 2025 7:00 am |
RNS |
GSK’s Shingrix Fully Liquid FDA approval |
| 17th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 15th Jul 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 15th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 14th Jul 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 14th Jul 2025 7:00 am |
RNS |
GSK submits Arexvy for adults 18-49 AIR to FDA |
| 14th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 11th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 10th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 9th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 8th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 7th Jul 2025 4:00 pm |
RNS |
GSK completes acquisition of efimosfermin for SLD |
| 7th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 4th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 3rd Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 2nd Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 1st Jul 2025 3:00 pm |
RNS |
Total Voting Rights |
| 1st Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 30th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 27th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 26th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 25th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 24th Jun 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 24th Jun 2025 3:00 pm |
RNS |
Director Declaration |
| 24th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 23rd Jun 2025 5:50 pm |
RNS |
Replacement - Director/PDMR Shareholding |
| 23rd Jun 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Jun 2025 8:30 am |
RNS |
Replacement RNS: Linerixibat file accepted by EMA |
| 23rd Jun 2025 8:18 am |
RNS |
GSK Submits Arexvy for adults 18+ with EMA |
| 23rd Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 20th Jun 2025 7:00 am |
RNS |
Arexvy filed in Japan for 18-49 at increased risk |
| 20th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 19th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 18th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 17th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 13th Jun 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
